Skip to content
Tirzepatide Report
Provider review

OnlineSemaglutide.org Tirzepatide Review: Redirect & Prices

Researched & written by Alan PierceClinical Pharmacology WriterUpdated

On this page

The original domain leads to Raeliva’s named subscription offers; a redirect does not establish agreement continuity.

Standout details

  • Named destination page separates full bills from rounded monthly equivalents
  • Public cancellation instructions promise written confirmation

Things to consider

  • Longer plans are paid upfront; rounded $267/$242 amounts are not monthly installments
  • No-charge-if-inappropriate product wording differs from completed-consultation nonrefund clauses

OnlineSemaglutide.org currently redirects to Raeliva. The destination publishes a named compounded tirzepatide injection offer with monthly and prepaid options. A redirect shows the current destination; it does not by itself prove a corporate rename, continuity of an old patient agreement, or transfer of records and payments.3,4

Compare the destination’s full billed totals

Raeliva’s named tirzepatide injection page lists $299 billed monthly, $800 billed every three months, and $1,450 billed every six months. The longer plans display approximately $267/month and $242/month. Their FAQ expressly says multi-month plans are charged upfront as a single charge, not as monthly payments.4

The Open Water Rx review also distinguishes prepaid supply offers from general recurring-subscription terms. Compare the charge due now and the agreement authorizing the next purchase, not just the monthly equivalent.

The equivalents are rounded. Budget the $800 or $1,450 bill rather than multiplying the rounded headline to reconstruct a different total. Ask when the next full charge occurs and how medication is shipped across the paid term. A six-month purchase does not prove that every prescribed vial arrives in one shipment.4

The page says medication, provider review, refill coordination and ongoing support are included, with no price increase solely because the prescribed dose changes. These are published inclusion claims, not a quote accepted for an individual prescription or confirmation of stock, clinical eligibility or services outside the selected plan.4

Raeliva destination: billed totals

Published detailQuestion before committing
Monthly plan: $299Confirm the next charge and supplied period.
Three months: $800 upfrontAbout $267 per month is a rounded equivalent.
Six months: $1,450 upfrontAbout $242 per month does not create monthly installments.
These are destination public tirzepatide injection offers, not proof of an earlier agreement’s terms.3,4

Cancellation needs confirmation before the next charge

The product FAQ and site describe subscriptions that can be canceled by contacting support or messaging the care team. They promise written confirmation and say no further charges occur once cancellation is confirmed. Obtain the next charge date and confirmation rather than assuming a message automatically cancels an already-processed order.4,5

The refund policy says orders can be canceled only before prescription processing; once medication is prescribed or prepared for shipment, it cannot be changed or refunded. Ending future subscription charges is separate from recalling medication or refunding unused time in a prepaid term.6

Approval marketing and evaluation fees need one answer

The product says there is nothing to pay if a licensed provider determines treatment is inappropriate after reviewing the intake. The Terms say completed medical consultations are nonrefundable, and prescription sales are final. The refund policy lists treatment unable to proceed after consultation as a possible refund situation, while also excluding completed consultations.4,6,7

Ask whether any evaluation fee applies when no prescription is issued, what amount would be returned and how quickly. The policy describes 5–10 business days after refund confirmation, not a guaranteed timeline starting with every request. It also permits specified duplicate-charge and verified fulfillment-error refunds; these are narrower than an unconditional satisfaction guarantee.6

Raeliva: cancellation and refund

Published detailQuestion before committing
No further charges after cancellation is confirmedGet written confirmation before the next renewal.
Prescription processing is an order cutoffFuture cancellation does not recall processed medication.
Completed consultations called nonrefundableResolve the no-prescription fee outcome against product wording.
Approved refunds: 5–10 business days after confirmationA request alone does not establish approval or start this period.
The product approval claim and the medical-evaluation clauses require an offer-specific answer.4,5,6,7

Named networks are not a personal assignment

Raeliva’s About page identifies Pacific Shores Research Group LLC as platform operator, Lion MDs as an independent medical practice, and CareValidate as the patient-management technology provider. It names a pharmacy network including Belmar and Strive. Those disclosures do not establish the actual clinician, prescription, preparing/dispensing facility or current credentials assigned to a particular person.8

Existing OnlineSemaglutide.org customers should ask who holds their agreement and records, which billing and cancellation terms apply, and whether any new authorization is required. The destination’s current marketing does not establish that an old subscription ended, transferred or acquired these prices.3,7

The medicine is separate from the platform

Compounded tirzepatide is not an FDA-approved finished drug.9 SURMOUNT-1 and SURMOUNT-5 studied specific tirzepatide products and protocols, not this platform’s compounded preparation, service or testimonials. Those trials provide background about the medicine; they do not establish the platform’s results or the equivalence of oral and injectable formulations.1,2 A clinician must assess the individual prescription and explain its risks, alternatives and instructions.

Further reading

whether compounded tirzepatide is still legal in 2026 · Zepbound side effects · the gallbladder risk · thyroid cancer warning · tirzepatide evidence guide · Ondra Health · NewSelf · Open Water Rx · best tirzepatide providers

Frequently asked questions

Where does OnlineSemaglutide.org lead now?

It redirects to Raeliva. That navigation does not establish a corporate rename, transfer of an existing patient agreement, or continuity of records and billing.

Can I pay $242 month to month for Raeliva tirzepatide?

The named injection page shows $1,450 upfront for six months, advertised as about $242 per month. The monthly plan is $299; the three-month option is $800 upfront. Confirm the prescribed plan and next charge.

Will I pay nothing if treatment is declined?

The product says nothing is payable if treatment is inappropriate, while legal pages call completed consultations nonrefundable and describe qualified refund cases. Obtain the offer-specific evaluation-fee and refund outcome before paying.

References(9)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. OnlineSemaglutide.org / Raeliva (2026). Original domain: current redirect to Raeliva. OnlineSemaglutide.org / Raeliva.
  4. Raeliva (2026). Tirzepatide injections: named billing totals and prepaid-plan FAQ. Raeliva. Read source
  5. Raeliva (2026). FAQ: subscription cancellation and program descriptions. Raeliva. Read source
  6. Raeliva (2026). Refund and Return Policy. Raeliva. Read source
  7. Raeliva (2026). Terms and Conditions: payments, consultations and platform role. Raeliva. Read source
  8. Raeliva (2026). About: operator, medical practice, technology and pharmacy network. Raeliva. Read source
  9. U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration. Read source

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.